Alchemy is an Italian company established in 1998, dedicated to offering synthetic and analytical services to pharmaceutical and biotech Companies, along with providing research and development services to private and academic research Institutes. Our objective is to foster enduring partnerships with our Clients by delivering effective chemistry services and economical solutions.
Since its inception, custom synthesis has been the primary focus of Alchemy. We specialize in preparing and characterizing various compounds, whether based on existing literature, customer protocols, or through the exploration and development of new synthetic routes.
Alchemy aids pharmaceutical companies in their Medicinal Chemistry endeavours across the preclinical stages of drug Research & Development.
Our custom synthesis services encompass the synthesis of:
Alchemy possesses the capability to swiftly develop scalable, reliable, and economical chemical processes optimizing reaction conditions for intermediates or final products.
Alchemy can carry out the identification and quantification of impurities in Active Pharmaceutical Ingredients (API) and formulated products. This activity is comprehensive, spanning all aspects of pharmaceutical production from research and development to the final market release.
Alchemy’s analytical department is dedicated to analytical Research and Development (R&D) and Quality Control, serving both our internal synthetic department and pharmaceutical companies. We utilize advanced software, Fusion QbD, which enables us to expedite method development and validation in a more efficient manner.
Contact us for:
We are authorized by the Italian Medicinal Agency (AIFA) to conduct Quality Control testing in adherence to Good Manufacturing Practices (GMP Certificate No. aM-72/2023).
Alchemy has the capability to develop and validate UPLC/HPLC methods for analysing Active Pharmaceutical Ingredients (API) and other chemical entities.
Development of highly robust and easily validated UPLC/ HPLC methods for the analysis of API and other chemical entities for Pharmaceutical Industry using the AQbD approach according to the ICH Q14 guideline.
Alchemy supports Italian users of FUSION QbD® the S-Matrix software platform for xPLC method development.
ADDRESS
Alchemy Srl Via Saragat, 18 – 40052 Baricella (BO) – Italy
PHONES
0039 051.87.4519
FAX
0039 051.6620661
VAT N. IT 01859771204
R.E.A. 396075
Cap.soc. 20.000,00 € int. vers.
Iscritta al Registro Imprese di Bologna al n. 50893